JPMORGAN CHASE & CO

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$31,439,291	1,010,260	+701,127	+227%	$31.12	Q4 2025
30 Sep 2025	0%	-0%	$6,671,090	309,133	-106,856	-26%	$21.58	Q3 2025
30 Jun 2025	0%	+0%	$5,815,525	415,989	+117,439	+39%	$13.98	Q2 2025
31 Mar 2025	0%	-0%	$4,024,455	298,550	-5,784		$13.48	Q1 2025
31 Dec 2024	0%	-0%	$5,834,083	304,334	-96,017	-24%	$19.17	Q4 2024
30 Sep 2024	0%	+0%	$9,107,986	400,351	+274,641	+218%	$22.75	Q3 2024
30 Jun 2024	0%	+0%	$1,635,487	125,710	+76,687	+156%	$13.01	Q2 2024
31 Mar 2024	0%	-0%	$858,392	49,023	-7,915	-14%	$17.51	Q1 2024
31 Dec 2023	0%	+0%	$1,240,110	56,938	+6,016	+12%	$21.78	Q4 2023
30 Sep 2023	0%	-0%	$781,143	50,922	-9,050	-15%	$15.34	Q3 2023
30 Jun 2023	0%	+0%	$1,426,734	59,972	+10,595	+21%	$23.79	Q2 2023
31 Mar 2023	0%	-0%	$1,256,000	49,377	-122,982	-71%	$25.44	Q1 2023
31 Dec 2022	0%	+0%	$5,034,000	172,359	+103,101	+149%	$29.21	Q4 2022
30 Sep 2022	0%	+0%	$1,421,000	69,258	+50,989	+279%	$20.52	Q3 2022
30 Jun 2022		0%	$1,000	70	0		$14.29 ^*	Q2 2022
30 Jun 2022	0%	-0%	$212,000	18,269	-397	-2.1%	$11.60	Q2 2022
31 Mar 2022	0%	+0%	$345,000	18,666	+5,633	+43%	$18.48	Q1 2022
31 Dec 2021	0%	+0%	$258,000	13,033	+13,033	NEW	$19.80	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.